Vanderbilt-Ingram Cancer Center, Vanderbilt University — Nashville, Tennessee

Vanderbilt-Ingram Cancer Center, Vanderbilt University is a clinical research site located in Nashville, Tennessee, United States 37232.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Vanderbilt-Ingram Cancer Center, Vanderbilt University has participated in 1 clinical trials.

Therapeutic areas: Leukemia, Lymphoma.

Sponsors: Virginia Commonwealth University.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt-Ingram Cancer Center, Vanderbilt University?

Vanderbilt-Ingram Cancer Center, Vanderbilt University has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt-Ingram Cancer Center, Vanderbilt University conducted?

Vanderbilt-Ingram Cancer Center, Vanderbilt University has 1 clinical trials on record. Their work covers Leukemia, Lymphoma.

Is Vanderbilt-Ingram Cancer Center, Vanderbilt University accredited by Crixeo Health?

Vanderbilt-Ingram Cancer Center, Vanderbilt University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt-Ingram Cancer Center, Vanderbilt University?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.